Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.

Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.

Although growth hormone (GH) replacement therapy is increasingly utilized in the management of adult hypopituitary patients, optimum dosing schedules are poorly defined. The use of weight-based or surface area-based dosing may result in overtreatment, and individual variation in susceptibility on th...

Ամբողջական նկարագրություն

Մատենագիտական մանրամասներ
Հիմնական հեղինակներ:	Drake, WM, Coyte, D, Camacho-Hübner, C, Jivanji, N, Kaltsas, G, Wood, D, Trainer, P, Grossman, AB, Besser, G, Monson, J
Ձևաչափ:	Journal article
Լեզու:	English
Հրապարակվել է:	1998

Նմանատիպ նյութեր

Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.
‌: Florakis, D, և այլն
Հրապարակվել է: (2000)

Comments on 'Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two-year study' by Florakis et al (2000) - Reply
‌: Monson, J, և այլն
Հրապարակվել է: (2001)

Hypothalamo-pituitary surveillance imaging in hypopituitary patients receiving long-term GH replacement therapy.
‌: Frajese, G, և այլն
Հրապարակվել է: (2001)

Safety of GH replacement in hypopituitary patients with nonirradiated pituitary and peripituitary tumours.
‌: Chung, T, և այլն
Հրապարակվել է: (2008)

Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients.
‌: Agha, A, և այլն
Հրապարակվել է: (2007)

Growth hormone replacement does not increase serum prostate-specific antigen in hypopituitary men over 50 years.
‌: le Roux, C, և այլն
Հրապարակվել է: (2002)

Role of fasting plasma glucose, glycated haemoglobin and homeostatic model assessment in the detection of glucose intolerance in adult hypopituitary patients during growth hormone replacement therapy.
‌: Colson, A, և այլն
Հրապարակվել է: (2008)

Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement.
‌: Chung, T, և այլն
Հրապարակվել է: (2005)

Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity.
‌: Kaltsas, G, և այլն
Հրապարակվել է: (2001)

Insulin-like growth factor-I and- II in combination inhibit the release of growth hormone-releasing hormone from the rat hypothalamus in vitro.
‌: Korbonits, M, և այլն
Հրապարակվել է: (1996)

The effect of growth hormone (GH) replacement therapy on sympathetic nerve hyperactivity in hypopituitary adults: a double-blind, placebo-controlled, crossover, short-term trial followed by long-term open GH replacement in hypopituitary adults.
‌: Sverrisdóttir, Y, և այլն
Հրապարակվել է: (2003)

Optimal dosage interval for depot somatostatin analogue therapy in acromegaly requires individual titration.
‌: Jenkins, P, և այլն
Հրապարակվել է: (2000)

Growth hormone deficiency and replacement in patients with treated Cushing's Disease, prolactinomas and non-functioning pituitary adenomas: effects on body composition, glucose metabolism, lipid status and bone mineral density.
‌: Colson, A, և այլն
Հրապարակվել է: (2006)

The modulation of platelet function by growth hormone in growth hormone deficient Hypopituitary patients
‌: Irene K Oglesby, և այլն
Հրապարակվել է: (2023-09-01)

The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin.
‌: Korbonits, M, և այլն
Հրապարակվել է: (1999)

Hexarelin as a test of pituitary reserve in patients with pituitary disease.
‌: Korbonits, M, և այլն
Հրապարակվել է: (1999)

Pyridostigmine partially reverses dexamethasone-induced inhibition of the growth hormone response to growth hormone-releasing hormone.
‌: Trainer, P, և այլն
Հրապարակվել է: (1992)

Authors' response: The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women
‌: Kaltsas, G, և այլն
Հրապարակվել է: (2003)

The prevalence and characteristic features of cyclicity and variability in Cushing's disease.
‌: Alexandraki, K, և այլն
Հրապարակվել է: (2009)

How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
‌: Kaltsas, G, և այլն
Հրապարակվել է: (2000)

Classic cardiovascular risk factors improve in very elderly hypopituitary patients treated on standard hormone replacement in long term follow- up
‌: Isabella Naves Rosa, և այլն
Հրապարակվել է: (2021-03-01)

CT appearance of the adrenal glands in adrenocorticotrophic hormone-dependent Cushing's syndrome.
‌: Sohaib, SA, և այլն
Հրապարակվել է: (1999)

Complications of inferior petrosel sinus sampling.
‌: Kaltsas, G, և այլն
Հրապարակվել է: (2000)

Circulating Levels of Irisin in Hypopituitary and Normal Subjects.
‌: Lara Pena-Bello, և այլն
Հրապարակվել է: (2016-01-01)

Benzodiazepines attenuate the pituitary-adrenal responses to corticotrophin-releasing hormone in healthy volunteers, but not in patients with Cushing's syndrome.
‌: Korbonits, M, և այլն
Հրապարակվել է: (1995)

Prevalence and risk factors of the metabolic syndrome in young adults with childhood-onset hypopituitary growth hormone deficiency
‌: Han Hyuk Lim, և այլն
Հրապարակվել է: (2010-10-01)

Gamma knife radiosurgery: a safe and effective salvage treatment for pituitary tumours not controlled despite conventional radiotherapy.
‌: Swords, F, և այլն
Հրապարակվել է: (2009)

The role of cytotoxic chemotherapy in the management of aggressive and malignant pituitary tumors.
‌: Kaltsas, G, և այլն
Հրապարակվել է: (1998)

Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
‌: Isidori, A, և այլն
Հրապարակվել է: (2003)

Male-female differences in 6-sulfatoxymelatonin excretion in hypopituitary patients
‌: Hugo L. Fideleff, և այլն
Հրապարակվել է: (2016-02-01)

Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome.
‌: Newell-Price, J, և այլն
Հրապարակվել է: (2002)

NITRIC-OXIDE AS A NOVEL REGULATOR OF NEUROENDOCRINE FUNCTION - CONTROL OF CORTICOTROPIN-RELEASING HORMONE-41 RELEASE FROM THE RAT HYPOTHALAMUS INVITRO
‌: Costa, A, և այլն
Հրապարակվել է: (1992)

Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
‌: Korbonits, M, և այլն
Հրապարակվել է: (1998)

A rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemia.
‌: Miraki-Moud, F, և այլն
Հրապարակվել է: (2005)

A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome.
‌: Kaltsas, G, և այլն
Հրապարակվել է: (1999)

Initial response of young people with thyrotoxicosis to block and replace or dose titration thionamide
‌: Claire L Wood, և այլն
Հրապարակվել է: (2023-01-01)

Clinical, radiological and pathological features of patients with Rathke's cleft cysts: tumors that may recur.
‌: Mukherjee, J, և այլն
Հրապարակվել է: (1997)

BENZODIAZEPINES ATTENUATE THE SERUM CORTISOL RESPONSE TO CORTICOTROPIN-RELEASING HORMONE (CRH) IN HEALTHY-VOLUNTEERS
‌: Trainer, P, և այլն
Հրապարակվել է: (1992)

No clear evidence for an association between GH replacement and relapse of intracranial germ cell tumours: single centre and KIMS experience.
‌: Chung, T, և այլն
Հրապարակվել է: (2010)

Nitric oxide modulates the release of corticotropin-releasing hormone from the rat hypothalamus in vitro.
‌: Costa, A, և այլն
Հրապարակվել է: (1993)